Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Multicenter Clinical Study Evaluating the Efficacy and Safety of Axicabtagene Ciloleucel Injection Manufactured by an Automated Process in Patients With Relapsed/Refractory Large B-cell Lymphoma.

NCT07606937 is registered in ClinicalTrials.gov with Shenzhen Fosun Kairos Biotechnology Co., Ltd. as lead sponsor.

NCT NCT07606937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07606937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Multicenter Clinical Study Evaluating the Efficacy and Safety of Axicabtagene Ciloleucel Injection Manufactured by an Automated Process in Patients With Relapsed/Refractory Large B-cell Lymphoma.
Lead sponsor
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
June 12, 2026
Completion date
December 31, 2026
Enrollment
12 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory large b-cell lymphoma